Anti-ERBB1/EGFR/HER1 Antibody (Depatuxizumab)
Catalog No.
F1417
Anti-ERBB1/EGFR/HER1 Antibody (Depatuxizumab)
Featured Products
Depatuxizumab is a humanized, tumor-specific, anti-EGFR monoclonal antibody that is brain-penetrant. Depatuxizumab inhibits the growth of mutant EGFRvIII and wild-type EGFR xenograft tumor models. Depatuxizumab can be used in cancer research.
144.54 kDa
Dry ice
1471999-69-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
mAb806, LICR 806, ABT-806
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
The purity of Anti-ERBB1/EGFR/HER1 Antibody (Depatuxizumab) is 99.58%, determined by SEC-HPLC.
ERBB1 / EGFR / HER1
Please avoid freeze-thaw cycles.